Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News HTG Molecular Diagnostics Inc. HTGM

HTG Molecular Diagnostics Inc is a commercial stage RNA platform-based life sciences company focused on advancing the promise of precision medicine. Its proprietary NGS-adapted chemistry and HTG EdgeSeq platform automates sample processing and can quickly, robustly and simultaneously profile hundreds or thousands of molecular targets using a relatively small amount of biological sample, in liquid or solid forms. Its products include instruments, consumables and software that combine to form...


Recent & Breaking News (NDAQ:HTGM)

HTG Technology Featured Across Numerous Abstracts at Upcoming Scientific Conferences

GlobeNewswire 2 days ago

HTG Molecular Diagnostics Reports Third Quarter 2022 Results

GlobeNewswire November 10, 2022

HTG to Collaborate With OmiCure, Providing Transcriptomic Data Across Several Cancer Indications

GlobeNewswire October 26, 2022

HTG Provides Update on Third Quarter Progress Toward Its Transcriptome-Informed Approach to Drug Discovery

GlobeNewswire October 12, 2022

HTG Molecular Diagnostics to Participate in the Cantor Fitzgerald Oncology, Hematology & HemeOnc Conference

GlobeNewswire September 26, 2022

The Fundación Instituto Valenciano de Oncología Leverages HTG Technology for Breast Cancer Laboratory-Developed Test

GlobeNewswire September 20, 2022

HTG Molecular Diagnostics Reports Second Quarter 2022 Results

GlobeNewswire August 11, 2022

HTG Molecular Diagnostics to Announce Q2 2022 Financial Results and Host Conference Call on Thursday, August 11

GlobeNewswire August 4, 2022

HTG Molecular Diagnostics Hosting a KOL Event Addressing Drug Candidate Attrition

GlobeNewswire July 19, 2022

HTG Molecular Diagnostics Announces Amendment to Senior Loan Facility

GlobeNewswire July 18, 2022

HTG Releases Second Whitepaper for its Transcriptome-Informed Approach to Drug Discovery

GlobeNewswire July 6, 2022

Publication Highlights Potential Clinical Applications of the HTG Transcriptome Panel in Bladder Cancer

GlobeNewswire June 29, 2022

HTG to Sponsor Keynote Presentation Featuring Customer Use of its HTG EdgeSeq Technology in Clinical Trials

GlobeNewswire June 8, 2022

HTG Technology Featured in Multiple Scientific Abstracts Highlighting Novel Applications in Precision Medicine at ASCO 2022

GlobeNewswire June 6, 2022

REVISION - HTG to Host Scientific Webinar Featuring Customer Use of the HTG Transcriptome Panel in Preclinical and Clinical Programs

GlobeNewswire June 1, 2022

HTG to Host Scientific Webinar Featuring Customer Use of the HTG Transcriptome Panel in Preclinical and Clinical Programs

GlobeNewswire June 1, 2022

HTG Molecular Diagnostics to Participate in the H.C. Wainwright Global Investment Conference

GlobeNewswire May 17, 2022

HTG Molecular Diagnostics Reports First Quarter 2022 Results

GlobeNewswire May 12, 2022

HTG Molecular Diagnostics to Announce Q1 2022 Financial Results and Host Conference Call on Thursday, May 12

GlobeNewswire May 5, 2022

HTG Expands Therapeutics Team

GlobeNewswire April 13, 2022